To access all features and enjoy the full functionality of this site, please ensure your browser is up-to-date. For IE8 users, the most recent version is IE11.

TECNIS Odyssey™ IOL

TECNIS

Odyssey IOL

 

Precise vision. Every distance.

Any lighting.1-3

 

Enhanced Tolerance to Refractive Error†4   Optimized Dysphotopsia Profile†5   Outstanding Range of Vision**¶†2   Best-in-Class Contrast¶†3,6,7  
Enhanced Tolerance to Refractive Error†4
Optimized Dysphotopsia Profile†5
Outstanding Range of Vision**¶†2
Best-in-Class Contrast¶†3,6,7

 

Delivering

Exceptional Patient

Satisfactionˆ

94%

Satisfaction with overall vision
without glasses.8

 

96%

Satisfaction with reading on a
smartphone or tablet.9

 

92%

Satisfaction with ability to see steps
and curbs at night.9

Optimized Dysphotopsia Profile

 

Freeform diffractive profile contributes to a low incidence
of bothersome visual disturbances.10

 

93% reported none or mild halos, glare or starbursts at one month post-op10

*According to ISO11979-7:2024, based on the clinical study of the parent IOL
¶Compared to PanOptix® based on bench testing
†Compared to TECNIS Synergy™ OptiBlue™ IOL based on bench testing
**Continuous 20/25 or better
ˆValues rounded to the nearest 1%. Based on 3-month postoperative data from a multicenter, observational clinical study in the U.S.

 

REFERENCES

1. 2024DOF4002 TECNIS Odyssey™ Full Visual Range IOL.
2. DOF2023CT4023 – Simulated VA of the TECNIS Odyssey™ IOL, model DRN00V, and PanOptix® IOL, model TFNT00. April 3, 2023.
3. DOF2023CT4007 – MTF of TECNIS Odyssey™lenses. 15 March 2023.
4. 2024DOF4003 – Simulated tolerance to refractive error (defocus) of the TECNIS Odyssey™ IOL. Feb. 7, 2024.
5. 2024DOF4005 – Laboratory measurement of intensity of extended objects for halo illustration of TECNIS Odyssey™ and PanOptix. Feb. 14, 2024.
6. DOF2019OTH4002 – MTF of the TECNIS Synergy™ OptiBlue™ IOL, and other lens models. 27 March 2019.
7. 2024DOF4033 – MTF of Clareon PanOptix lenses.
8. 2024DOF4027 – User acceptability evaluation of pseudophakic patients previously implanted with the TECNIS Odyssey™ IOL. PATIENT REPORTED SPECTACLE INDEPENDENCE QUESTIONNAIRE (PRSIQ). 11 June 2024
9. 2024DOF4029 – User acceptability evaluation of pseudophakic patients previously implanted with the TECNIS Odyssey™ IOL. LOW-LIGHT VISION QUESTIONNAIRE OUTCOMES. 11 June 2024
10. DOF2023CT4050 – Evaluation of real-world data on the performance of the TECNIS Odyssey™ IOL. DYSPHOTOPSIA OUTCOMES. 5 Feb 2024.

 

 

For healthcare professionals only. Please reference the Instructions for Use for a complete list of Indications and Important Safety Information and contact our specialists in case of any question.

 

©Johnson & Johnson and its affiliates 2025. All rights reserved.

2024PP17394